Industry News

Industry News

ADA Board Approves $20 Million in Budget Cuts for 2025
 
The American Dental Association (ADA) Board of Trustees approved more than $20 million in expense reductions as part of its 2025 budget. The cuts, approved in July, follow years of deficit spending and reserve fund use.

Programs and initiatives affected include the Leadership Institute, Advisory Committee on Equity, Inclusion and Interprofessional Relationships, and the Large Group/Multi-site Practice Engagement Task Force. The AFI Certified Program and ADA Loyalty Program will not launch.

Changes also include reducing staff, shifting most trustee and council meetings to virtual, scaling back live continuing education to annual scientific sessions, and limiting the association’s presence at dental conferences.

ADA President Brett Kessler, DDS, said the adjustments are necessary to address financial strain and move toward a balanced budget. President-elect Richard J. Rosato, DMD, emphasized the association’s continued focus on science, education, practice, advocacy, and membership.

For more information, visit ada.org.


HuFriedyGroup Names Robert Woolley CEO
Industry News 
Robert Woolley, a veteran medtech executive, will succeed Andy Xilas as the CEO of HuFriedyGroup. Xilas, who has been the CEO since January 2021, led the company through significant growth and transformation, including its divestiture from STERIS plc. Woolley brings more than two decades of global medical device and dental experience to lead the company in its next phase of growth and innovation. He joins HuFriedyGroup from Sonova Group, where he most recently served as group vice president of Hearing Instruments. Previously, he held key executive roles at Straumann Group, including executive vice president for North America and Western Europe.

For more information, visit hufriedygroup.com.


Henry Schein $750 Million Share Repurchase Plan
Industry News  
Henry Schein, Inc. announces a $750 million stock buyback program, in addition to a previous $500 million program. The company’s board of directors authorized the repurchase of shares, representing approximately 9% of shares outstanding. The buyback is part of Henry Schein’s confidence in its 2025–2027 strategic plan for sustainable growth and value. With a strong balance sheet, the company aims to expand its health care solutions.

For more information, visit henryschein.com.


Pearl Becomes First Dental AI Company FDA-Cleared for 2D and 3D Imaging
Industry News 
Pearl has received FDA 510(k) clearance for Second Opinion 3D, becoming the first dental AI company with FDA-cleared solutions for both 2D and 3D dental radiologic image analysis. The clearance expands the platform’s capabilities to CBCT imaging, allowing automated identification of key anatomical structures in 3D scans, including dentition, maxilla, mandible, inferior alveolar canal, mental foramen, maxillary sinus, nasal space, and airway. The software is designed to help dental professionals review CBCT images more efficiently, and support diagnostics and treatment planning across specialties.

For more information, visit hellopearl.com.


Pac-Dent, Inc. Acquires Ackuretta Technologies
Industry News 
Pac-Dent, Inc. announced the acquisition of Taiwan-based Ackuretta Technologies, a developer of dental laboratory and chairside 3D printing hardware. The move expands Pac-Dent’s open-system digital dentistry platform by integrating Ackuretta’s printer technology and Alpha AI CAM software with Pac-Dent’s portfolio of materials and workflow solutions.

As part of the integration, Pac-Dent is preparing technical support in North America for Ackuretta products, including spare parts distribution, training resources, and workflow guidance.

For more information, visit pac-dent.com.


Sponsors
Townie Perks
Townie® Poll
Who or what do you turn to for most financial advice regarding your practice?
  
The Dentaltown Team, Farran Media Support
Phone: +1-480-445-9710
Email: support@farranmedia.com
©2025 Dentaltown, a division of Farran Media • All Rights Reserved
9633 S. 48th Street Suite 200 • Phoenix, AZ 85044 • Phone:+1-480-598-0001 • Fax:+1-480-598-3450